Definitely a good opportunity to top up considering the expected news flow within this and early next quarter imo..
1. ARDS - Update
" Pre-IND meeting with the FDA regarding clinical trial development program"
"Camargo will report these results to FDA in a comprehensive information package which will also outline future clinical development plans for IHL-675A"
+ further information on proceedings with new conditions"" IBD
, COPD, asthma and bronchitis• Incannex will now expand its discussions with research organisations and regulators to continue a
clinical and regulatory strategy and these n
egotiations are ongoing. ""
work your magic Camargo!!
2. Further information re the psychedelics program and trial #2
3. An update re-OSA
4. An update re dual listing considering Eddie sugars options have been sorted